Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 4, 2012, Pages 1268-1276

  Cheng, Hui Teng ^a   Huang, Jenq Wen ^a   Chiang, Chih Kang ^a   Yen, Chung Jen ^a   Hung, Kuan Yu ^a   Wu, Kwan Dun ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGED; AGED, 80 AND OVER; AGING; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; MALE; METABOLIC SYNDROME X; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TAIWAN;

EID: 84859543673     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2658     Document Type: Article

References (36)

1. Ford ES, Giles WH, Dietz WH 2002 Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356-359 (Pubitemid 34251969)
2. Kitiyakara C, Yamwong S, Cheepudomwit S, Domrongkitchaiporn S, Unkurapinun N, Pakpeankitvatana V, Sritara P 2007 The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort. Kidney Int 71:693-700 (Pubitemid 46494568)
3. Kurella M, Lo JC, Chertow GM 2005 Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16:2134-2140 (Pubitemid 41716445)
4. Ninomiya T, Kiyohara Y, Kubo M, Yonemoto K, Tanizaki Y, Doi Y, Hirakata H, Iida M 2006 Metabolic syndrome and CKD in a general Japanese population: the Hisayama study. Am J Kidney Dis 48:383-391 (Pubitemid 44247252)
5. Tanaka H, Shiohira Y, Uezu Y, Higa A, Iseki K 2006 Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int 69:369-374 (Pubitemid 43323089)
6. Haas JT, Biddinger SB 2009 Dissecting the role of insulin resistance in the metabolic syndrome. Curr Opin Lipidol 20:206-210
7. Huang PL 2009 A comprehensive definition for metabolic syndrome. Dis Model Mech 2:231-237
8. Chen J, Muntner P, Hamm LL, Fonseca V, Batuman V, Whelton PK, He J 2003 Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 14:469-477 (Pubitemid 36150872)
9. Landau M, Kurella-Tamura M, Shlipak MG, Kanaya A, Strotmeyer E, Koster A, Satterfield S, Simsonick EM, Goodpaster B, Newman AB, Fried LF 2011 Correlates of insulin resistance in older individuals with and without kidney disease. Nephrol Dial Transplant 26: 2814-2819
10. Reaven G 2004 The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol Metab Clin North Am 33:283-303 (Pubitemid 38680631)
11. El-Atat FA, Stas SN, McFarlane SI, Sowers JR 2004 The relationship between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol 15:2816-2827 (Pubitemid 41103390)
12. Kobayashi H, Tokudome G, Hara Y, Sugano N, Endo S, Suetsugu Y, Kuriyama S, Hosoya T 2009 Insulin resistance is a risk factor for the progression of chronic kidney disease. Clin Nephrol 71:643-651
13. Bastürk T, Unsal A 2011 Is insulin resistance a risk factor for the progression of chronic kidney disease? Kidney Blood Press Res 34: 111-115
14. Lea J, Cheek D, Thornley-Brown D, Appel L, Agodoa L, Contreras G, Gassman J, Lash J, Miller 3rd ER, Randall O, Wang X, McClellan W 2008 Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African Americans. Am J Kidney Dis 51: 732-740 (Pubitemid 351626250)
15. Lee CC, Sun CY, Wu IW, Wang SY, Wu MS 2011 Metabolic syndrome loses its predictive power in late-stage chronic kidney disease progression-a paradoxical phenomenon. Clin Nephrol 75:141-149
16. 2001 Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419 (Pubitemid 15018832)
18. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS 2007 Prevalence of chronic kidney disease in the United States. JAMA 298:2038-2047 (Pubitemid 350074801)
19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D 1999 A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461-470 (Pubitemid 29135798)
20. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G 2003 National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137-147
21. Klein R, Klein BE, Moss SE, Cruickshanks KJ, Brazy PC 1999 The 10-year incidence of renal insufficiency in people with type 1 diabetes. Diabetes Care 22:743-751 (Pubitemid 29220773)
22. Fried L, Solomon C, Shlipak M, Seliger S, Stehman-Breen C, Bleyer AJ, Chaves P, Furberg C, Kuller L, Newman A 2004 Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol 15:3184-3191 (Pubitemid 39578851)
23. Whaley-Connell A, Pavey BS, McCullough PA, Saab G, Li S, McFarlane SI, Chen SC, Vassalotti JA, Collins AJ, Bakris G, Sowers JR 2010 Dysglycemia predicts cardiovascular and kidney disease in the Kidney Early Evaluation Program. J Clin Hypertens (Greenwich) 12:51-58
24. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J 2004 The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140:167-174
25. Rowe JW, Minaker KL, Pallotta JA, Flier JS 1983 Characterization of the insulin resistance of aging. J Clin Invest 71:1581-1587 (Pubitemid 13056763)
26. Muller DC, Elahi D, Tobin JD, Andres R 1996 The effect of age on insulin resistance and secretion: a review. Semin Nephrol 16:289-298 (Pubitemid 26239458)
27. Gerich JE 1997 Metabolic abnormalities in impaired glucose tolerance. Metabolism 46:40-43
28. Egan BM, Greene EL, Goodfriend TL 2001 Insulin resistance and cardiovascular disease. Am J Hypertens 14:116S-125S (Pubitemid 32506705)
29. Hostetter TH, Rennke HG, Brenner BM 1982 The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72:375-380 (Pubitemid 12188669)
30. Tsimihodimos V, Dounousi E, Siamopoulos KC 2008 Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treatment. Am J Nephrol 28:958-973
31. Samuelsson O, Attman PO, Knight-Gibson C, Larsson R, Mulec H, Weiss L, Alaupovic P 1998 Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency. J Am Soc Nephrol 9:1482-1488 (Pubitemid 28354559)
32. Tozawa M, Iseki K, Iseki C, Oshiro S, Ikemiya Y, Takishita S 2002 Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria. Kidney Int 62:1743-1749 (Pubitemid 35286282)
33. Hadjadj S, Duly-Bouhanick B, Bekherraz A, BrIdoux F, Gallois Y, Mauco G, Ebran J, Marre M 2004 Serum triglycerides are a predictive factor for the development and the progression of renal and retinal complications in patients with type 1 diabetes. Diabetes Metab 30:43-51 (Pubitemid 38418942)
34. Lee PH, Chang HY, Tung CW, Hsu YC, Lei CC, Chang HH, Yang HF, Lu LC, Jong MC, Chen CY, Fang KY, Chao YS, Shih YH, Lin CL 2009 Hypertriglyceridemia: an independent risk factor of chronic kidney disease in Taiwanese adults. Am J Med Sci 338:185-189
35. Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Mänttäri M, Heinonen OP, Frick MH 1992 Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation 85:37-45
36. Zuo L, Ma YC, Zhou YH, Wang M, Xu GB, Wang HY 2005 Application of GFR-estimating equations in Chinese patients with chronic kidney disease. Am J Kidney Dis 45:463-472 (Pubitemid 40341325)